|
1
|
Shearman CP and Windhaber R: Foot
complications in patients with diabetes. Surgery. 28:288–292.
2010.
|
|
2
|
Dieter RS, Chu WW, Pacanowski JP Jr,
McBride PE and Tanke TE: The significance of lower extremity
peripheral arterial disease. Clin Cardiol. 25:3–10. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calne RY, Gan SU and Lee KO: Stem cell and
gene therapies for diabetes mellitus. Nat Rev Endocrinol.
6:173–177. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dequach JA, Lin JE, Cam C, Hu D, Salvatore
MA, Sheikh F and Christman KL: Injectable skeletal muscle matrix
hydrogel promotes neovascularization and muscle cell infiltration
in a hindlimb ischemia model. Eur Cell Mater. 23:400–412. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang PP, Yang XF, Li SZ, Wen JC, Zhang Y
and Han ZC: Randomised comparison of G-CSF-mobilized peripheral
blood mononuclear cells versus bone marrow-mononuclear cells for
the treatment of patients with lower limb arteriosclerosis
obliterans. Thromb Haemost. 98:1335–1342. 2007.PubMed/NCBI
|
|
6
|
Waksman R and Baffour R: Bone marrow and
bone marrow derived mononuclear stem cells therapy for the
chronically ischemic myocardium. Cardiovasc Radiat Med. 4:164–168.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hayashida K, Fujita J, Miyake Y, Kawada H,
Ando K, Ogawa S and Fukuda K: Bone marrow-derived cells contribute
to pulmonary vascular remodeling in hypoxia-induced pulmonary
hypertension. Chest. 127:1793–1798. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tateishi-Yuyama E, Matsubara H, Murohara
T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto
K, Akashi H, et al: Therapeutic angiogenesis for patients with limb
ischaemia by autologous transplantation of bone-marrow cells: A
pilot study and a randomised controlled trial. Lancet. 360:427–435.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Furth ME and Atala A: Stem cell sources to
treat diabetes. J Cell Biochem. 106:507–511. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Todd JA: Stem cells and a cure for type 1
diabetes? Proc Natl Acad Sci USA. 106:pp. 15523–15524. 2009;
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Urbán VS, Kiss J, Kovács J, Gócza E, Vas
V, Monostori E and Uher F: Mesenchymal stem cells cooperate with
bone marrow cells in therapy of diabetes. Stem Cells. 26:244–253.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dubský M, Jirkovská A, Bém R, Pagácová L,
Fejfarová V, Varga M, Skibová J, Langkramer S and Syková E:
Treatment of critical limb ischemia and diabetic foot disease by
the use of autologous stem cells. Vnitr Lek. 57:451–455. 2011.(In
Czech). PubMed/NCBI
|
|
13
|
Kirana S, Stratmann B, Prante C, Prohaska
W, Koerperich H, Lammers D, Gastens MH, Quast T, Negrean M, Stirban
OA, et al: Autologous stem cell therapy in the treatment of limb
ischaemia induced chronic tissue ulcers of diabetic foot patients.
Int J Clin Pract. 66:384–393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
De Haro J, Acin F, Lopez-Quintana A,
Florez A, Martinez-Aguilar E and Varela C: Meta-analysis of
randomized, controlled clinical trials in angiogenesis: Gene and
cell therapy inperipheral arterial disease. Heart Vessels.
24:321–328. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hirata K, Li TS, Nishida M, Ito H,
Matsuzaki M, Kasaoka S and Hamano K: Autologous bone marrow cell
implantation as therapeutic angiogenesis for ischemic hindlimb in
diabetic rat model. Am J Physiol Heart Circ Physiol. 284:H66–H70.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee KB, Choi J, Cho SB, Chung JY, Moon ES,
Kim NS and Han HJ: Topical embryonic stem cells enhance wound
healing in diabetic rats. J Orthop Res. 29:1554–1562. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park SJ, Moon SH, Lee HJ, Lim JJ, Kim JM,
Seo J, Yoo JW, Kim OJ, Kang SW and Chung HM: A comparison of human
cord blood- and embryonic stem cell-derived endothelial progenitor
cells in the treatment of chronic wounds. Biomaterials.
34:995–1003. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shin L and Peterson DA: Human mesenchymal
stem cell grafts enhance normal and impaired wound healing by
recruiting existing endogenous tissue stem/progenitor cells. Stem
Cells Transl Med. 2:33–42. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakayama Y, Iwahana M, Sakamoto N, Tanaka
NG and Osada Y: Inhibitory effects of a bacteria-derived sulfated
polysaccharide against basic fibroblast growth factor-induced
endothelial cell growth and chemotaxis. J Cell Physiol. 154:1–6.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leask A: Potential therapeutic targets for
cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2 and PDGF,
partners in fibroblast activation. Circ Res. 106:1675–1680. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lott JA and Turner K: Evaluation of
Trinder's glucose oxidase method for measuring glucose in serum and
urine. Clin Chem. 21:1754–1760. 1975.PubMed/NCBI
|
|
22
|
Zhang Q, Xiao X, Feng K, Wang T, Li W,
Yuan T, Sun X, Sun Q, Xiang H and Wang H: Berberine moderates
glucose and lipid metabolism through multipathway mechanism. Evid
Based Complement Alternat Med 2011. pii:9248512011.
|
|
23
|
Schnedl WJ, Krause R, Halwachs-Baumann G,
Trinker M, Lipp RW and Krejs GJ: Evaluation of HbA1c determination
methods in patients with hemoglobinopathies. Diabetes Care.
23:339–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun L, Zhou X, Zhang TL, Zhang G, Zuo M,
Li J, Huang G, Lu D, Guang X and Yang D: Isolation, labeling and
culture of bone marrow-derived mononuclear cells. Chin J Cardiovasc
Rev. 777–779. 2008.(In Chinese).
|
|
25
|
Gu YQ, Zhang J, Guo LR, Qi LX, Zhang SW,
Xu J, Li JX, Luo T, Ji BX, Li XF, et al: Transplantation of
autologous bone marrow mononuclear cells for patients with lower
limb ischemia. Chin Med J (Engl). 121:963–967. 2008.PubMed/NCBI
|
|
26
|
Das AK: Stem cell therapy for critical
limb ischaemia-a review. Indian J Surg. 71:177–181. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Benoit E, O'Donnell TF and Patel AN:
Safety and efficacy of autologous cell therapy in critical limb
ischemia: A systematic review. Cell Transplant. 22:545–562. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koleva-Georgieva DN, Sivkova NP and
Terzieva D: Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha
and VEGF have influence on the development of diabetic retinopathy.
Folia Med (Plovdiv). 53:44–50. 2011.PubMed/NCBI
|
|
29
|
Kaul K, Hodgkinson A, Tarr JM, Kohner EM
and Chibber R: Is inflammation a common retinal-renal-nerve
pathogenic link in diabetes? Curr Diabetes Rev. 6:294–303. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Carranza K and Veron D, Cercado A,
Bautista N, Pozo W, Tufro A and Veron D: Cellular and molecular
aspects of diabetic nephropathy; the role of VEGF-A. Nefrologia.
35:131–138. 2015.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dabhi B, Mistry KN, Patel H and Lal S:
Vascular endothelial growth factor insertion/deletion gene
polymorphism in West Indian patients of type 2 diabetes and
diabetic nephropathy. Indian J Biochem Biophys. 52:209–212.
2015.PubMed/NCBI
|
|
32
|
Hatsukami TS, Primozich J, Zierler RE and
Strandness DE Jr: Color Doppler characteristics in normal lower
extremity arteries. Ultrasound Med Biol. 18:167–171. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tan O, Yuce I, Kantarci M and Algan S:
Evaluation of lower-limb arteries with multidetector computed
tomography angiography prior to free flap surgery: A radioanatomic
study. J Reconstr Microsurg. 27:199–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Graziani L, Silvestro A, Bertone V, Manara
E, Andreini R, Sigala A, Mingardi R and De Giglio R: Vascular
involvement in diabetic subjects with ischemic foot ulcer: A new
morphologic categorization of disease severity. Eur J Vasc Endovasc
Surg. 33:453–460. 2007. View Article : Google Scholar : PubMed/NCBI
|
